BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34497714)

  • 1. High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19.
    Chavarria AP; Lezama ES; Navarro MG; Vazquez RRV; Bello HH; Gascon JL; Juárez LM; Avendaño MA; Gonzalez LER; Ville Benavides R; Wyssmann RVÁ; Ortiz BS; de la Cerda MLR; Castañeda LM; Martinez-Juarez LA; Gallardo-Rincón H; Tapia-Conyer R
    Ther Adv Infect Dis; 2021; 8():20499361211042959. PubMed ID: 34497714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study.
    Alshahrani MS; Alshaqaq HM; Alhumaid J; Binammar AA; AlSalem KH; Alghamdi A; Abdulhady A; Yehia M; AlSulaibikh A; Al Jumaan M; Albuli WH; Ibrahim T; Yousef AA; Almubarak Y; Alhazzani W
    Saudi J Med Med Sci; 2021; 9(3):215-222. PubMed ID: 34667467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.
    Hirabayashi R; Nagata K; Sato Y; Nakagawa A; Tachikawa R; Kuroda H; Seo R; Morimoto T; Tomii K
    BMC Pulm Med; 2023 Aug; 23(1):294. PubMed ID: 37559018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.
    Vega ML; Dongilli R; Olaizola G; Colaianni N; Sayat MC; Pisani L; Romagnoli M; Spoladore G; Prediletto I; Montiel G; Nava S
    Pulmonology; 2022; 28(1):13-17. PubMed ID: 34049831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
    Reyes LF; Murthy S; Garcia-Gallo E; Merson L; Ibáñez-Prada ED; Rello J; Fuentes YV; Martin-Loeches I; Bozza F; Duque S; Taccone FS; Fowler RA; Kartsonaki C; Gonçalves BP; Citarella BW; Aryal D; Burhan E; Cummings MJ; Delmas C; Diaz R; Figueiredo-Mello C; Hashmi M; Panda PK; Jiménez MP; Rincon DFB; Thomson D; Nichol A; Marshall JC; Olliaro PL;
    Crit Care; 2022 Sep; 26(1):276. PubMed ID: 36100904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors.
    Raboni SM; Neves VC; Silva RM; Breda GL; Ceregato AC; Broza TP; de Oliveira G; Melo-Diaz LL; Braga CB; Carraro CF; Arroyo NC; Bardy RF; Devetak GF; Ozawa CM; Graf ME; Dias VL; Ducroquet MA; Nunes DP; Sokoloski CS; Petterle RR
    Respir Care; 2022 Nov; 67(11):1443-1451. PubMed ID: 35944966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
    Hu M; Zhou Q; Zheng R; Li X; Ling J; Chen Y; Jia J; Xie C
    BMC Pulm Med; 2020 Dec; 20(1):324. PubMed ID: 33357219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily ROX index can predict transitioning to mechanical ventilation within the next 24 h in COVID-19 patients on HFNC.
    de Carvalho VCP; da Silva Guimarães BL; Fujihara MTF; Ceotto VF; Turon R; Lugon JR; Gismondi RAOC
    Am J Emerg Med; 2023 Nov; 73():160-165. PubMed ID: 37688983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Noninvasive Respiratory Support Failure in COVID-19 Patients: A Prospective Observational Study.
    Zablockis R; Šlekytė G; Mereškevičienė R; Kėvelaitienė K; Zablockienė B; Danila E
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744032
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.
    Ait Hamou Z; Levy N; Charpentier J; Mira JP; Jamme M; Jozwiak M
    Respir Res; 2022 Dec; 23(1):329. PubMed ID: 36463161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Tada Y; Tsushima K
    Respir Investig; 2022 Jan; 60(1):146-153. PubMed ID: 34772644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.
    Zhou X; Liu J; Pan J; Xu Z; Xu J
    BMC Pulm Med; 2022 Apr; 22(1):121. PubMed ID: 35365110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure.
    Xu J; Yang X; Huang C; Zou X; Zhou T; Pan S; Yang L; Wu Y; Ouyang Y; Wang Y; Xu D; Zhao X; Shu H; Jiang Y; Xiong W; Ren L; Liu H; Yuan Y; Qi H; Fu S; Chen D; Zhang D; Yuan S; Shang Y
    Front Med (Lausanne); 2020; 7():607821. PubMed ID: 33425951
    [No Abstract]   [Full Text] [Related]  

  • 15. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate.
    Goh KJ; Chai HZ; Ong TH; Sewa DW; Phua GC; Tan QL
    J Intensive Care; 2020; 8():41. PubMed ID: 32587703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of high flow oxygen therapy failure in COVID-19-related severe hypoxemic respiratory failure.
    Polydora E; Alexandrou M; Tsipilis S; Athanasiou N; Katsoulis M; Rodopoulou A; Pappas A; Kalomenidis I
    J Thorac Dis; 2022 Apr; 14(4):851-856. PubMed ID: 35572875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the use of the respiratory-rate oxygenation index as a predictor of high-flow nasal cannula oxygen failure in COVID-19.
    Weerasuriya S; Vlachos S; Bobo A; Jayaprabhu NB; Matthews L; Blackstock AR; Metaxa V
    Acute Crit Care; 2023 Feb; 38(1):31-40. PubMed ID: 36935532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Flow Nasal Cannula oxygen therapy in COVID-19: retrospective analysis of clinical outcomes - single center experience.
    Obradović D; Milovančev A; Plećaš Đurić A; Sovilj-Gmizić S; Đurović V; Šović J; Đurđević M; Tubić S; Bulajić J; Mišić M; Jojić J; Pušara M; Lazić I; Đurković M; Bek Pupovac R; Vulić A; Jozing M
    Front Med (Lausanne); 2023; 10():1244650. PubMed ID: 37849487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
    Roca O; Caralt B; Messika J; Samper M; Sztrymf B; Hernández G; García-de-Acilu M; Frat JP; Masclans JR; Ricard JD
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1368-1376. PubMed ID: 30576221
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].
    Liu T; Zhao Q; Shi Z; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):686-691. PubMed ID: 34296687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.